source
- FDA proposes removing obesity and diabetes drug ingredients from compounding substances listThe U.S. Food and Drug Administration has issued a proposal to remove the active ingredients of widely used obesity and diabetes medicines from the list of substances that can be compounded. The ch…
- Psychedelic boom risks sidelining people of color despite new federal push and AbbVie's billion-dollar dealThe piece highlights that psychedelics are being praised for their therapeutic potential but still face scientific uncertainty and political debate. President Trump signed an executive order aimed…